Molecular classification and prognosis in younger adults with acute myeloid leukemia and intermediate‐risk cytogenetics treated or not by gemtuzumab ozogamycin: Final results of the GOELAMS/FILO acute myeloid leukemia 2006‐intermediate‐risk trial - Bouvier, Anne; Hamel, Jean‐François; Delaunay, Jacques; Delabesse, Eric; Dumas, Pierre‐Yves; Ledoux, Marie‐Pierre; Peterlin, Pierre; Luquet, Isabelle; Roth Guepin, Gabrielle; Bulabois, Claude Eric; Gallego Hernanz, Maria Pilar; Guillerm, Gaëlle; et al. (European Journal of Haematology, 2021)